Dual Diagnosis

How Anxiety Shapes Daily Life & What Effective Treatment in Florida Looks Like

Begin Recovery

The average time needed for a full ADHD evaluation is anywhere from one hour to several hours. Evaluations generally include clinical interviews, standardized questionnaires, cognitive testing, and possibly meetings with family members. The goal is to differentiate ADHD from other psychiatric disorders that have similar symptoms.

Inattentive ADHD symptoms include difficulty maintaining focus, being easily distracted, disorganization, forgetfulness, difficulty completing tasks, losing items, and difficulty with reading or maintaining focus for a prolonged period of time. Adults with inattentive ADHD do not exhibit signs of hyperactivity and, as a result, are often overlooked in adult populations.

Yes. Studies show that people diagnosed with ADHD have a greater risk of developing substance use disorder compared to non-ADHD populations. People with ADHD experience significantly different brain chemistry patterns than those without ADHD, and this contributes to their attraction to certain substances, making it necessary for dual diagnosis programs to address both issues simultaneously.

Yes. While some ADHD medications are stimulants such as Ritalin or Adderall, there are non-stimulant alternatives, including atomoxetine (Strattera), guanfacine (Intuniv), and bupropion (Wellbutrin). Non-stimulant medications are safe alternatives for those with a history of substance use disorder. Therapy, behavioral techniques, and lifestyle changes also provide the foundation for effective ADHD treatment.

Yes. At Forward Motion Health, we believe that addressing both substance use disorder and ADHD should occur together through a multidisciplinary team rather than through separate treatment approaches.

[1] [9] American Psychiatric Association. (2022). Attention-deficit/hyperactivity disorder. In Diagnostic and statistical manual of mental disorders (5th ed., text rev.).

https://www.psychiatry.org/patients-families/adhd/what-is-adhd

 

[2] [4] Volkow, N. D., Wang, G. J., Newcorn, J., Kollins, S., Wigal, T., Telang, F., Fowler, J., Goldstein, R., Klein, N., Logan, J., Wong, C., Swanson, J., & Schulz, K. (2011). Motivation deficit in ADHD is associated with dysfunction of the dopamine reward pathway. Molecular Psychiatry, 16(11), 1147–1154. https://www.nature.com/articles/mp201097


[3] Faraone, S. V., & Larsson, H. (2019). Genetics of attention deficit hyperactivity disorder. Molecular Psychiatry, 24(4), 562–575. https://doi.org/10.1038/s41380-018-0070-0 

 

[5] [6] Banerjee, T. D., Middleton, F., & Faraone, S. V. (2007). Environmental risk factors for attention-deficit hyperactivity disorder. Acta Paediatrica, 96(9), 1269–1274. https://doi.org/10.1111/j.1651-2227.2007.00430.x

[7] Nigg, J. T., Nikolas, M., Knottnerus, G. M., Cavanagh, K., & Friderici, K. (2010). Confirmation and extension of association of blood lead with attention-deficit/hyperactivity disorder (ADHD) and ADHD symptom domains at population-typical exposure levels. Journal of Child Psychology and Psychiatry, 51(1), 58–65. https://doi.org/10.1111/j.1469-7610.2009.02135.x

[8] Quinn, P. O., & Madhoo, M. (2014). A review of attention-deficit/hyperactivity disorder in women and girls: Uncovering this hidden diagnosis. The Primary Care Companion for CNS Disorders, 16(3). https://doi.org/10.4088/PCC.13r01596 

[10] Lee, S. S., Humphreys, K. L., Flory, K., Liu, R., & Glass, K. (2011). Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: A meta-analytic review. Clinical Psychology Review, 31(3), 328–341. https://pmc.ncbi.nlm.nih.gov/articles/PMC3180912/

[11] Magon, R., & Müller, U. (2012). ADHD with comorbid substance use disorder: Review of treatment. Advances in Psychiatric Treatment, 18(6), 436–446. https://doi.org/10.1192/apt.bp.111.009340

Call 24/7
Verify Insurance